Newborn heelstick blood collection can be a painful procedure in part because of the time required to obtain sufficient quantity of blood. No previous studies have determined whether local vasodilatation using topical nitroglycerine ointment (NGO) would facilitate heelstick blood collection.
INTRODUCTION
Heelstick blood collection is probably the most common painful procedure performed on newborns. Studies confirm that infants undergoing this procedure experience significant pain manifested by crying, facial expressions, body movements and physiologic changes. 1, 2 Interventions previously demonstrated to reduce the pain and distress of heelsticks include the use of automated spring-loaded devices, 3 nonnutritive sucking, 4 rocking, 5 skin-to-skin contact 6 and oral sucrose. 7 Ineffective measures include topical anesthesia (EMLA) 8 and oral analgesics (acetaminophen). 9 One reason that heelstick blood collection is painful and distressing is the prolonged squeezing of the heel required to complete the collection. We reasoned that any intervention reducing the duration of the heelstick blood collection would be associated with reduced pain and distress.
Nitroglycerine produces vasodilatation through its nitric oxide effect on veins and arteries. When used topically, nitroglycerine ointment (NGO) produces local vasodilatation and has been used in adults and children to facilitate venipuncture or intravenous cannulation. 10, 11 In small amounts, its systemic absorption is insignificant and side effects such as hypotension and methemoglobinemia can be avoided. We designed this study to determine if topical NGO would safely reduce the collection time and associated pain/distress with heelstick blood collection for routine newborn metabolic screening. We postulated that newborns receiving NGO would have reduced collection time, reduced crying time, fewer needlesticks required and reduced heart rate acceleration compared to those receiving placebo ointment.
METHODS Patients
Full-term newborns in the normal nursery at Hartford Hospital born between 2/1/00 and 4/1/00 about to undergo heelstick blood collection were recruited. Patients who had been in the NICU or those with any cardiovascular or neurologic abnormalities were excluded. Background clinical variables recorded included birth weight, gestational age, gender, type of delivery (vaginal vs cesarean) and previous heelstick for another reason. Following written informed parental consent, infants were randomized by use of sealed envelopes to either study NGO or placebo.
Protocol
Study infants were brought to the testing room and connected to cardiac and noninvasive blood pressure monitors. Baseline BP and heart rate were measured. The infant's behavior state before ointment application was recorded (asleep/awake-quiet/ awake-fussy/awake crying). The time elapsed since previous feeding was also noted. One of four study nurses recruited from the newborn nursing staff applied 0.25 ml of ointment (NGO or placebo) to the heel. As per usual nursery routine, the heel was then wrapped with a warm soak (using a washcloth and warm tap water) for 10 minutes. During this time, heart rates were recorded every minute directly from the monitor digital read-out. At the completion of 10 minutes, a repeat BP was measured, the ointment removed with alcohol and the heelstick performed by the nurse using a standard nonautomated lancet. Blood (approximately 1 ml) was collected directly onto filter paper as per laboratory guidelines and usual nursery routine. The need for additional heelstick to complete the collection was at the nurse's discretion. The collection time and crying time were recorded using a stopwatch by the study coordinator. The study ended at completion of the blood collection.
Ointments
Syringes of ointment were prepared in the pharmacy. Study ointment consisted of NGO diluted in lanolin to a final concentration of 0.2%, so that 0.25 ml of ointment delivered 0.5 mg nitroglycerine. The placebo (lanolin), indistinguishable from NGO, was applied in equal volume (0.25 ml) to control infants. Patients were randomly assigned to NGO or placebo using cards in sealed individual envelopes. Only the pharmacist knew the ointment code until patient enrollment and data analysis was completed.
Data Analysis
The sample size of 50 patients (25 in each group) was designed to detect a 25% reduction in collection time with a power of 80% and a significance level of 0.05. Data were analyzed using unpaired t-test, Fisher exact test, or w 2 test as appropriate. A p-value of <0.05 was considered significant. Hartford Hospital's institutional review board approved the study and written informed parental consent was obtained after the natures of the procedures were fully explained.
RESULTS
A total of 50 infants were studied, 25 in each group. There were no differences between the groups in mode of delivery, BW, GA, APGAR scores, method of feeding, time since last feed, baseline behavioral state prior to heelstick or experience with previous heelstick. The time (seconds) to complete the blood collection was [mean±1SD] 269±250 in the NGO group compared with 250±142 in controls (NS). The proportion (%) of collection time spent crying was 85±25 in the NGO group compared with 90±18 in controls (NS). The number of infants requiring more than one heelstick to complete the collection was 6 of 25 (24%) in the NGO group compared with three of 25 (12%) in controls (NS). Heart rates (bpm) increased significantly in both groups in response to the procedure: preheelstick 128±13; postheelstick 172±16 (p<0.001), but no difference was seen between groups. There were no changes in BP before and after NGO.
DISCUSSION
The cutaneous vasodilatation produced by NGO has been shown to facilitate venipuncture or intravenous cannulation in adults and young infants. 10, 11 In contrast, a small study in neonates found less successful intravenous cannulation and an excess of bleeding and infiltration in the NGO group compared to controls. 12 Nevertheless, we speculated that while the local vasodilatory effects may not help (and may actually hinder) venous cannulation in newborns, such effects might benefit heelstick blood collection. The lack of such benefit noted in the current study may be because of a number of factors. Infants in both the NGO and control groups had their heels warmed prior to heelstick. Since this was the standard in our nursery, we were reluctant to omit this step for the patients randomized to control ointment. Nevertheless, the vasodilatation induced by warming may have blunted any effect from NGO. Interestingly, a recently published report finding no benefit to heel warming prior to heelstick blood collection when using an automated incision device calls into question the need for prewarming. 13 Alternatively, the dose of NGO used (0.5 mg) may have been insufficient to achieve adequate vasodilatation although this dose is comparable to amounts used in previous studies. No systemic effect of NGO (hypotension) was noted with this dose, but monitoring for this complication as well as methemoglobinemia would be important in any future studies employing larger doses of NGO.
A limitation of the study was the lack of one individual performing all heelsticks. Differences in collection time were seen between nurses but did not reach statistical significance. Further, each nurse had an equal distribution of patients receiving either NGO or placebo. Each study nurse was experienced in the procedure such that the collection time for the 1 ml of blood in this study (269 seconds in the NGO group and 250 seconds in the placebo group) approximated the collection time using a similar lancet in a recent study 14 where only 0.4 ml of blood was required. Utilizing more than one staff nurse for such clinical studies strengthens the relevance of findings to the general nursery setting.
Owing to its ease and safety, heel lancing is the most common method of obtaining blood both for metabolic screening in healthy term infants and for routine testing in the NICU. Attempts to reduce the pain associated with the procedure have had mixed results. Spring-loaded automated devices reduce the blood Nitroglycerine Ointment for Heelstick Blood Collection Cecchi et al.
sampling time and cause less physiologic instability than conventional heel lancets, but are considerably more expensive than standard lancets. 12 Pretreatment with oral sucrose, 6 and behavioral interventions such as rocking and nonnutritive sucking 5 and skin-to-skin contact 13 have been shown to reduce pain expression. In contrast, neither local anesthetic cream (EMLA) 7 nor pretreatment with acetaminophen 8 was effective in reducing pain. Venipuncture as an alternative to heel lance in term infants undergoing blood collection for routine metabolic screening was studied by Larsson et al. 14 They found that venipuncture reduced collection time, number of punctures required to complete the collection, pain scores and crying. They emphasized that most of the discomfort from the procedure occurs during the heel squeezing phase subsequent to the incision. Their study employed a single trained neonatal intensive care nurse who performed all punctures. The lack of availability of such skilled phlebotomists in the normal nursery may limit this approach.
In conclusion, application of topical NGO did not facilitate heelstick blood collection in term infants. Current data support the use of automated heel-lancing devices in combination with oral sucrose, nutritive or nonnutritive sucking or skin-to-skin contact to reduce the pain/distress of this procedure. The feasibility of venipuncture in the general nursery setting as an alternative to heelstick for collecting blood for state-mandated metabolic screening deserves further study.
